AIR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AAR Corp is not a clear buy right now for a beginner long-term investor with $50,000-$100,000, especially given the absence of a strong proprietary buy signal and the mixed near-term setup. The stock has solid long-term business momentum and analyst support, but the current price is already near resistance and insider selling is elevated. My direct view: hold for now rather than buy immediately.
AIR is in a short-term bullish trend: MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. RSI_6 at 69.776 is elevated but still not flashing a strong overbought breakdown signal. Price at 114.7 is above the pivot (107.785) and just below R1 (113.836) / near R2 (117.574), which suggests the stock has already moved into resistance territory after the recent advance. Overall trend is constructive, but not an ideal fresh entry after the run-up.
Analysts are increasingly constructive, with multiple target raises and Buy/Overweight/Outperform ratings. KeyBanc raised its target to $132 and cited rising OEM order activity, restocking, and strong aftermarket conditions. Jefferies lifted its target to $150 after AAR raised 2026 organic growth guidance to 12%. RBC highlighted strong Q3 results, with revenue and EBITDA margins above expectations and broad-based strength in commercial and government sales. The news backdrop in aerospace also remains supportive, with expanding airline networks indicating healthy travel demand.
Insiders are selling, and selling has increased sharply over the last month. Hedge funds are neutral with no significant accumulation trend. The stock is trading near resistance after a strong move, and the short-term pattern analysis suggests downside risk over the next day/week/month. There is also no strong Intellectia proprietary signal today, which removes a key bullish trigger for immediate entry.
The latest quarter season referenced in the analyst commentary is Q3. Financials were described as strong: revenue and EBITDA margins came in ahead of expectations, commercial sales rose 27%, government sales rose 19%, and organic growth was reported at 14% in Q3 before management raised 2026 organic growth guidance to 12%. That points to healthy growth momentum and improving execution.
Analyst sentiment is clearly positive and improving. Recent rating changes show multiple firms raising price targets: KeyBanc to $132, Jefferies to $150, RBC to $125, KeyBanc earlier to $120, and Truist to $128. The pro side is strong growth, margin expansion, aftermarket strength, and value for long-term investors. The con side is that the stock has already run up, insider selling is increasing, and the current setup is more favorable for holding than chasing. Wall Street is broadly bullish, but the best immediate reward-to-risk is not outstanding at the current price.
